More than half of people with HIV now on antiretrovirals

accreditation
Many more HIV patients are now on antiretroviral medication. (iStock)
Many more HIV patients are now on antiretroviral medication. (iStock)

For the first time in world history, more than half the people living with HIV are on treatment, according to the latest Ending Aids report by the Joint United Nations Programme on HIV/Aids (UNAIDS).

The UNAIDS targets are that, by 2020, 90% of people living with HIV should know their status, 90% of these people should be on ARVs and 90% of people on treatment should have suppressed viral loads.

'A strong return on investment'

Released this morning (Thursday 20 July), the report notes that as of 2016, 19.5 million people were on antiretroviral treatment (ART), up from 17.1 million in 2015. Six out of 10 people on ART live in eastern and southern Africa.

“With science showing that starting treatment as early as possible has the dual benefit of keeping people living with HIV healthy and preventing HIV transmission, many countries have now adopted the gold-standard policy of treat all,” said UNAIDS executive director Michel Sidibe´.

He said these efforts are bringing “a strong return on investment”. “Aids-related deaths have been cut by nearly half from the 2005 peak. We are seeing a downward trend in new HIV infections, especially in eastern and southern Africa, where new HIV infections have declined by a third in just six years.”

We live in fragile times

The southern and eastern African region is the most affected by HIV. Despite having the largest ART programme in the world, South Africa’s treatment coverage – 56% of all people living with HIV – was below the regional average of 60%. Botswana (83%) and Rwanda (80%) had the highest treatment coverage in the region.

Although South Africa has some way to go to increase access to treatment, the country has played a significant role in making viral load testing available in developing countries, according to the report. This test is important to check that the HIV medication is working to suppress the virus in the blood.

“This expansion is partly the result of South Africa leveraging its market weight to reduce viral load test prices globally,” noted the report. An agreement entered into between the South African government and the drug company Roche has led to a number of different countries being able to afford to buy the technology including Ethiopia, Kenya and Nigeria.

“But our quest to end Aids has only just begun. We live in fragile times, where gains can be easily reversed,” said Sidibe. “The biggest challenge to moving forward is complacency.” – Health-e News.

Read more:

Death rate halved, but HIV remains SA's biggest killer

South Africa celebrates ten years of free HIV treatment

Early HIV treatment best

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
The ANC's leadership race is heating up. Who do you think will be elected party president at Nasrec in December?
Please select an option Oops! Something went wrong, please try again later.
Results
Nkosazana Dlamini-Zuma has got it in the bag
7% - 723 votes
I foresee a second term for Cyril Ramaphosa
83% - 8511 votes
Don’t discount a Zweli Mkhize win
10% - 1016 votes
Vote
Rand - Dollar
17.75
+0.1%
Rand - Pound
20.17
-0.2%
Rand - Euro
17.60
-0.2%
Rand - Aus dollar
11.56
-0.2%
Rand - Yen
0.12
+0.2%
Gold
1,722.25
+0.3%
Silver
20.80
+0.8%
Palladium
2,267.00
+0.4%
Platinum
927.50
+0.6%
Brent Crude
93.37
+1.7%
Top 40
59,202
0.0%
All Share
65,613
0.0%
Resource 10
63,687
0.0%
Industrial 25
79,239
0.0%
Financial 15
13,961
0.0%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE